A Study of Multiple Ascending Doses of GSBR-1290 in Japanese and Non-Japanese Healthy Participants
Clinical trial NCT05893043 · COMPLETED
Trial details
- NCT number
- NCT05893043
- Sponsor
- Gasherbrum Bio, Inc., a wholly owned subsidiary of Structure Therapeutics
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-04-24
- Primary completion
- 2023-06-28
- Enrollment
- 18
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.